| Joseph G D'alton, MD | |
|
463 Worcester Rd, Suite 101, Framingham, MA 01701-5356 | |
| (508) 820-0469 | |
| (508) 626-1985 |
| Full Name | Joseph G D'alton |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 463 Worcester Rd, Framingham, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003993858 | NPI | - | NPPES |
| 3040348 | Medicaid | MA | |
| 710200 | Other | MA | TUFTS HEALTH PLAN |
| 30734 | Other | MA | FALLON |
| 11102 | Other | MA | HARVARD PILGRIM HEALTH PL |
| 48745 | Other | MA | AETNA/US HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 59459 (Massachusetts) | Primary |
| Entity Name | Neurological Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588703011 PECOS PAC ID: 8022191196 Enrollment ID: O20080213000016 |
News Archive
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism, a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.
According to a new scientific breakthrough, a device - a tiny, three-by-three millimetre microchip, has allowed patients with inherited blindness to detect objects with their eyes, unlike a rival approach that uses an external camera. The procedure details are outlined in the journal Proceedings of the Royal Society B.
Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.
Consuming the soy germ-based compound Natural S-equol and the supplement SE5-OH containing Natural S-equol did not increase the risk of estrogen-sensitive breast cancer, according to a study in the September issue of the peer-reviewed journal Food and Chemical Toxicology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph G D'alton, MD 463 Worcester Rd, Suite 101, Framingham, MA 01701-5356 Ph: (508) 820-0469 | Joseph G D'alton, MD 463 Worcester Rd, Suite 101, Framingham, MA 01701-5356 Ph: (508) 820-0469 |
News Archive
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism, a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.
According to a new scientific breakthrough, a device - a tiny, three-by-three millimetre microchip, has allowed patients with inherited blindness to detect objects with their eyes, unlike a rival approach that uses an external camera. The procedure details are outlined in the journal Proceedings of the Royal Society B.
Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.
Consuming the soy germ-based compound Natural S-equol and the supplement SE5-OH containing Natural S-equol did not increase the risk of estrogen-sensitive breast cancer, according to a study in the September issue of the peer-reviewed journal Food and Chemical Toxicology.
› Verified 3 days ago
Adriana Neagoe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 945 Concord St, Framingham, MA 01701 Phone: 508-283-7898 Fax: 508-764-2462 | |
Ashley Lee Shepard, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 201, Framingham, MA 01702 Phone: 508-845-1110 | |
Dr. Sean Orin Mackintosh, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Frederick Abbott Way, Framingham, MA 01701 Phone: 508-879-9800 Fax: 508-875-1348 | |
Dr. James Allen Kennedy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 88 Lincoln St, Framingham, MA 01702 Phone: 508-879-9800 | |
Robert Merle Johnston, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 354 Waverly St, Advocates Inc., Framingham, MA 01702 Phone: 508-661-2020 | |
Dr. Jacob Goldberg, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 359 Union Ave, Framingham, MA 01702 Phone: 508-620-1919 Fax: 508-820-3093 |